Taejeon-si, South Korea

Nak Jeong Kim




Average Co-Inventor Count = 10.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Taejon-si, KR (2002 - 2008)
  • Taejeon-si, KR (2007 - 2012)
  • Daejeon, KR (2013 - 2015)

Company Filing History:


Years Active: 2002-2015

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Nak Jeong Kim

Introduction

Nak Jeong Kim is a prominent inventor based in Taejeon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at preventing and treating various health conditions. With a total of 8 patents to his name, Kim's work has garnered attention in the scientific community.

Latest Patents

One of Kim's latest patents involves a pharmaceutical composition for preventing or treating osteoporosis or obesity. This composition comprises a phenyltetrazole derivative that is effective in regulating protein TAZ, which plays a crucial role in managing conditions such as osteoporosis, obesity, diabetes, and hyperlipidemia. The formula includes various components, such as ethyl or n-butyl, and different substituents that enhance its therapeutic efficacy.

Career Highlights

Throughout his career, Nak Jeong Kim has worked with notable organizations, including the Korea Research Institute of Chemical Technology and Dongbu Hannong Chemical Co., Ltd. His experience in these institutions has allowed him to develop innovative solutions in the pharmaceutical sector.

Collaborations

Kim has collaborated with esteemed colleagues, including Kyu Yang Yi and Jee Hee Suh. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Nak Jeong Kim's contributions to the field of pharmaceuticals highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…